🇺🇸 Placebo plus Docetaxel in United States

Placebo plus Docetaxel (Placebo plus Docetaxel) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Placebo plus Docetaxel in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is Placebo plus Docetaxel approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Placebo plus Docetaxel in United States?

Infinity Pharmaceuticals, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.